Impact of a short-term synbiotic supplementation on metabolic syndrome and systemic inflammation in elderly patients: a randomized placebo-controlled clinical trial.
Arrigo Francesco Giuseppe CiceroFederica FogacciMarilisa BoveMarina GiovanniniClaudio BorghiPublished in: European journal of nutrition (2020)
Treatment with a synbiotic formula of L. plantarum PBS067, L. acidophilus PBS066 and L. reuteri PBS072 with active prebiotics decreased MetS syndrome prevalence, several cardiovascular risk factors and markers of insulin resistance in elderly patients.
Keyphrases
- cardiovascular risk factors
- metabolic syndrome
- clinical trial
- double blind
- placebo controlled
- cardiovascular disease
- phase ii
- study protocol
- risk factors
- insulin resistance
- uric acid
- open label
- randomized controlled trial
- combination therapy
- type diabetes
- adipose tissue
- human milk
- radiation therapy
- phase ii study
- replacement therapy
- preterm birth